BMP used in pediatric surgeries without evidence of safety
A recent study on the use of the controversial bone growth material known as bone morphogenetic protein (BMP) shows that its off-label use includes the application in pediatric spinal fusion surgeries. Nearly 10 percent of all pediatric spinal fusion surgeries employ the use of BMP, a means of promoting new bone growth at the site … [Read more...] about BMP used in pediatric surgeries without evidence of safety
Medtronic Infuse Bone Graft Sales Continue Slide in Wake of Controversies
Device maker Medtronic Inc. saw sales of its Infuse Bone Graft product fall again in the first quarter of this fiscal year. According to to Medtronic's quarterly earnings report, Infuse sales shrank to $141 million in the first quarter of 2013, down from $174 million from the same time last year, a slide of 19%. The Infuse decline … [Read more...] about Medtronic Infuse Bone Graft Sales Continue Slide in Wake of Controversies
